Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on OGI shares. Stifel Nicolaus decreased their target price on OrganiGram from C$2.25 to C$1.50 in a research report on Friday, July 15th. Atb Cap Markets raised OrganiGram from a "sector perform" rating to an "outperform" rating in a research report on Tuesday, April 12th. Finally, Alliance Global Partners decreased their target price on OrganiGram from C$2.25 to C$1.50 in a research report on Friday, July 15th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $3.04.
OrganiGram Trading Up 0.9 %
Shares of OGI Stock traded up $0.01 on Friday, hitting $1.11. 997,733 shares of the stock were exchanged, compared to its average volume of 2,346,591. The firm has a market capitalization of $348.22 million, a PE ratio of -12.33 and a beta of 0.62. OrganiGram has a one year low of $0.90 and a one year high of $2.92. The firm's 50 day moving average is $1.04 and its two-hundred day moving average is $1.32.